Series date: 
01/01/2021 - 7:30am to 12/31/2021 - 7:30am

Mayo Clinic is committed to taking care of learners and staff during the COVID-19 pandemic.  Therefore, please be cognizant of, and abide by any current guidelines regarding in-person gatherings, while following Mayo Clinic recommendations and CPD’s COVID-19 resources page.

DESCRIPTION
Nephrology Hypertension Grand Rounds - This series is held weekly on Tuesday, 7:30 - 8:30 a.m.

Consultants, fellows and visiting professors present a 45 minute discussion topic which is intended to be a comprehensive review after which there is a 10-15 minute period for questions.  These "state-of-the-art" lectures are directed at the faculty and fellow level.  

TARGET AUDIENCE
The audience is primarily the physicians in our division, but all members of the division, i.e. nurses, NP/PAs and allied health staff are encouraged to attend.  We advertise the Grand Rounds title and speaker name throughout the institution which allows other areas/divisions to attend if they wish.  

LEARNING OBJECTIVES
Upon conclusion of this program, participants should be able to:

  • Integrate recent developments in Nephrology and Hypertension to their current practice.  
  • Summarize rationale for drug treatment choices based on advances in clinical trials.
  • Review basic mechanisms of disease and determine potential treatment target.
  • Debate with colleagues best practices and current standard of care.
  • Compare and critique various diagnostic as well as treatment strategies in Nephrology and Hypertension.

Accreditation Statement
In support of improving patient care, Mayo Clinic College of Medicine and Science is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.



Credit Statement(s):

AMA
Mayo Clinic College of Medicine and Science designates this live activity for a maximum of 1.00 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.


Disclosure Summary
As a provider accredited by Joint Accreditation Interprofessional Continuing Education, Mayo Clinic College of Medicine and Science (Mayo Clinic School of CPD) must ensure balance, independence, objectivity and scientific rigor in its educational activities. Course Director(s), Planning Committee Members, Faculty, and all others who are in a position to control the content of this educational activity are required to disclose all relevant financial relationships with any commercial interest related to the subject matter of the educational activity.  Safeguards against commercial bias have been put in place.  Faculty also will disclose any off label and/or investigational use of pharmaceuticals or instruments discussed in their presentation.  Disclosure of these relevant financial relationships will be published in activity materials so those participants in the activity may formulate their own judgments regarding the presentation.

Listed below are individuals with control of the content of this program who have disclosed...

Relevant financial relationship(s) with industry:
Hatem Amer, M.D.; Grant/Research Support, Department of Defense and Kaneka Pharma
John C. Lieske, M.D.; Consultant, Alnylam, Dicerna, Ofan, Synogic, Oxidien, Novobiome. Grant/Research Support: Allena, Dicerna, Alnylam.

No relevant financial relationship(s) with industry:
Robert C. Albright, Jr., D.O.
James R. Gregoire, M.D. 
Kianoush Kashani, M.D. 
Suzanne M. Norby, M.D. 
Sandra J. Taler, M.D.
Ms. Kathy Hegna Zelinske

For disclosure information regarding Mayo Clinic School of Continuous Professional Development accreditation review committee member(s), please go here.

ATTENDANCE/CREDIT
Text the session code (provided only at the session) to 507-200-3010 within 48 hours of the live presentation to record attendance.  All learners are encouraged to text attendance regardless of credit needs.  This number is only used for receiving text messages related to tracking attendance.  Additional tasks to obtain credit may be required based on the specific activity requirements and will be announced accordingly. Swiping your badge will not provide credit; that process is only applicable to meet GME requirements for Residents & Fellows. 

TRANSCRIPT
Any credit or attendance awarded from this series will appear on your Transcript.

COURSE DIRECTOR(S)
Hatem Amer, M.D.

QUESTIONS?
Contact Kathy Hegna Zelinske at phone 6-1044.

Where did the idea for the course originate?: 
Minnesota

Sessions

Session Date
**Attendance Only** Nephrology Hypertension Grand Rounds KSAP Volume 3, Module 2, Update (September 2020) Q1-15 July 27, 2021 07/27/2021 - 7:30am to 8:30am
Nephrology Hypertension Grand Rounds - nuSURF Student Presentations - August 3, 2021 08/03/2021 - 7:30am to 8:30am
Nephrology Hypertension Grand Rounds The Fundamentals of AV Fistulas, Fistulograms, and How Radiologists Can Assist Nephrologists August 10, 2021 08/10/2021 - 7:30am to 8:30am
**Attendance Only** Nephrology Hypertension Grand Rounds - KSAP Volume 3, Module 2, Update (September 2020) Q16-30 - August 17, 2021 08/17/2021 - 7:30am to 8:30am
Nephrology Hypertension Grand Rounds - Treatment of Obesity: Opening the Door and Improving Outcomes in Renal Transplantation - August 24, 2021 08/24/2021 - 7:30am to 8:30am
**Attendance Only** Nephrology Hypertension Grand Rounds KSAP Volume 3, Module 2, Update (September 2020) Question 31-45 August 31, 2021 08/31/2021 - 7:30am to 8:30am
CANCELLED - Nephrology Hypertension Grand Rounds - September 7, 2021 09/07/2021 - 7:30am to 8:30am
Nephrology Hypertension Grand Rounds - Health Effects of Climate Change - September 14, 2021 09/14/2021 - 7:30am to 8:30am
Nephrology Hypertension Grand Rounds - Change in the Trajectory of Diabetic Kidney Disease: where are we and where are we headed - September 21, 2021 09/21/2021 - 7:30am to 8:30am
ATTENDANCE ONLY - Nephrology Hypertension Grand Rounds - KSAP Volume 3, Module 2, Update (September 2020) Q 46-60 - September 28, 2021 09/28/2021 - 7:30am to 8:30am

Pages